#USA #Atlanta #Cardiovascular Health #Huxley Medical #SANSA platform

Huxley Medical Expands SANSA Diagnostic Platform

Huxley Medical has announced significant enhancements to its SANSA diagnostic platform aimed at revolutionizing sleep apnea testing availability in clinics and health systems. The company's latest offerings include SANSA GO™, a point-of-care enrollment model, and a new measure known as hypoxic burden, which indicates cardiovascular strain associated with sleep apnea. These additions underscore SANSA's unique status as the only multi-diagnostic monitor that can evaluate electrocardiograms (ECG), obstructive sleep apnea, and central sleep apnea using a single portable chest patch.

What is SANSA GO?

The SANSA GO model allows clinics to administer SANSA during patient visits, enabling more streamlined operations for busy health facilities. This innovation mimics successful access models seen in leading cardiac monitoring programs, integrating both clinic-based and home-testing options to cater to a growing patient population. Since its U.S. debut in 2025, SANSA has become increasingly popular among healthcare providers, being utilized by over a thousand physicians across various specializations including sleep medicine, cardiology, and general primary care. The system has enabled tests for tens of thousands of patients, demonstrating its potential to transform diagnostic procedures in these fields.

Addressing Sleep Apnea in Cardiology

As treatment methods for sleep apnea become more diverse—especially with new GLP-1 therapies that not only target sleep issues but also have implications on metabolic and cardiovascular health—the need for reliable home testing solutions continues to surge. Huxley Medical recognizes this need and aims to offer scalable testing tools that provide actionable insights across multiple health concerns. The SANSA GO and its complementary SANSA Express home enrollment model represent a significant leap in healthcare delivery for sleep apnea and related cardiovascular conditions.

Dr. Luigi Di Biase of Montefiore Einstein notes that SANSA simplifies the workflow for managing patients with atrial fibrillation, allowing easy transitions between administering ECG patches in the clinic and shipping them to patients for home use. He emphasizes that addressing underlying sleep apnea can significantly improve patient outcomes in those suffering from heart disease.

New Insights with Hypoxic Burden

The introduction of the hypoxic burden measure further enhances the SANSA platform’s ability to provide critical cardiovascular insights. A recent study involving 325 patients demonstrated that those with existing cardiovascular conditions—including atrial fibrillation—were over twice as likely to exhibit elevated hypoxic burdens.

Dr. Kunal Agarwal, a Medical Director at TidalHealth, valuable insights from SANSA's capabilities in helping to delineate which patients can be managed in primary care and which require immediate cardiology referrals. His approach highlights the Platform's potential in bridging the gap between sleep health and cardiovascular treatment, emphasizing the need for more integrated care pathways. His findings will be presented at the upcoming SLEEP 2026 meeting in Baltimore, Maryland.

Availability and Future Impact

Both the SANSA GO model and the hypoxic burden measure will be made available nationwide during the SLEEP 2026 conference from June 14 to June 17. This rollout presents an exciting opportunity for healthcare providers to enhance how they approach sleep-related health challenges.

Huxley Medical is committed to creating diagnostic solutions that make healthcare more accessible through innovative technologies. The SANSA platform represents a significant advancement in the diagnosis and management of both sleep disorders and cardiovascular health, reflecting the company's mission to provide efficient and effective patient care solutions.

For more information on Huxley Medical's offerings and the SANSA platform, potential users can visit Huxley Medical's website or contact them directly for specific inquiries.